GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Grand Brilliance Group Holdings Ltd (HKSE:08372) » Definitions » Change In Payables And Accrued Expense

Grand Brilliance Group Holdings (HKSE:08372) Change In Payables And Accrued Expense : HK$0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Grand Brilliance Group Holdings Change In Payables And Accrued Expense?

Grand Brilliance Group Holdings's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was HK$0.00 Mil. It means Grand Brilliance Group Holdings's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Sep. 2023 .

Grand Brilliance Group Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2023 was HK$0.00 Mil. It means Grand Brilliance Group Holdings's Accounts Payable & Accrued Expense stayed the same from Mar. 2022 to Mar. 2023 .


Grand Brilliance Group Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for Grand Brilliance Group Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Brilliance Group Holdings Change In Payables And Accrued Expense Chart

Grand Brilliance Group Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

Grand Brilliance Group Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Grand Brilliance Group Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grand Brilliance Group Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Grand Brilliance Group Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Brilliance Group Holdings (HKSE:08372) Business Description

Traded in Other Exchanges
N/A
Address
6 Sha Tsui Road, The Octagon, Units 2901-2903 and 2905, 29th Floor, New Territories, Tsuen Wan, Hong Kong, HKG
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
Executives
Miu Yin Shun Andrew 2202 Interest of your spouse
Wong Bik Kwan Bikie 2101 Beneficial owner
B&a Success Limited 2101 Beneficial owner

Grand Brilliance Group Holdings (HKSE:08372) Headlines

No Headlines